MapLight Therapeutics
Latest round
- Series D
Last raised
- Jul 2025
Total raised
- $238M
Investors
- 9
About MapLight Therapeutics
Founded in 2018 and based in Massachusetts, US, MapLight Therapeutics, Inc. operates as a biotechnology company that offers drugs to treat neurological and psychiatric disorders. The company was founded by its CEO, Christopher Kroeger, and Robert Malenka. In July 2025, MapLight Therapeutics, Inc.Rowe Price Investment Management, and Avego. MapLight Therapeutics develops drugs for people with neurological and neuropsychiatric disorders, including autism spectrum disorder, Parkinson's disease, schizophrenia, dyskinesias, and Alzheimer's disease psychosis. The firm offers a wide range of discovery platforms, including optogenetics, a laboratory technique that identifies cell types in the brain; transcriptomics, a platform that identifies the gene expression pattern of each cell type in the brain; and STARmap, a platform that identifies transcription patterns of each cell type in the brain. The company’s pipeline products include ML-004, a 5HT-1b agonist; ML-007C-MA, a muscarinic agonist; ML-007, a muscarinic receptor agonist; and ML-009.
Who invested in MapLight Therapeutics
9 investors across 2 rounds
See all investors in MapLight Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about MapLight Therapeutics
Who invested in MapLight Therapeutics?
MapLight Therapeutics has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has MapLight Therapeutics raised?
MapLight Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did MapLight Therapeutics last raise money?
MapLight Therapeutics's most recent round on record is a Series D, in Jul 2025.
What does MapLight Therapeutics do?
Founded in 2018 and based in Massachusetts, US, MapLight Therapeutics, Inc.
Where is MapLight Therapeutics headquartered?
MapLight Therapeutics is headquartered in Burlington, US.
Which VCs invest in companies like MapLight Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at MapLight Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like MapLight Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.